|
TIMM17A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45550000052452E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01159999999589E-05 |
| Normal-vs-Stage2 |
3.541800E-01 |
| Normal-vs-Stage3 |
1.90461999999281E-05 |
| Normal-vs-Stage4 |
1.77710000004438E-06 |
| Stage1-vs-Stage2 |
2.491000E-01 |
| Stage1-vs-Stage3 |
2.114200E-01 |
| Stage1-vs-Stage4 |
1.248200E-01 |
| Stage2-vs-Stage3 |
6.012100E-02 |
| Stage2-vs-Stage4 |
5.042500E-02 |
| Stage3-vs-Stage4 |
8.065400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.43269999594875E-08 |
| Normal-vs-AfricanAmerican |
1.783650E-01 |
| Normal-vs-Asian |
3.942200E-01 |
| Caucasian-vs-AfricanAmerican |
1.263150E-01 |
| Caucasian-vs-Asian |
7.643400E-01 |
| AfricanAmerican-vs-Asian |
7.934400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.66209959526509E-10 |
| Normal-vs-Female |
3.879700E-02 |
| Male-vs-Female |
1.136580E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.656200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.20909999474273E-08 |
| Normal-vs-Age(61-80Yrs) |
9.73669999999593E-05 |
| Normal-vs-Age(81-100Yrs) |
7.592600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.152400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.671200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.445590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.533610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.949390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.765000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.212400E-01 |
| Normal-vs-Grade 2 |
1.62828999999975E-05 |
| Normal-vs-Grade 3 |
1.80153000000072E-05 |
| Normal-vs-Grade 4 |
1.837400E-04 |
| Grade 1-vs-Grade 2 |
5.826000E-01 |
| Grade 1-vs-Grade 3 |
5.518600E-01 |
| Grade 1-vs-Grade 4 |
4.131800E-01 |
| Grade 2-vs-Grade 3 |
7.501800E-01 |
| Grade 2-vs-Grade 4 |
4.640800E-01 |
| Grade 3-vs-Grade 4 |
6.587600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.462200E-03 |
| Normal-vs-ccB subtype |
3.94099999967423E-07 |
| ccA subtype-vs-ccB subtype |
4.543800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69558999999486E-05 |
| Normal-vs-N1 |
7.386200E-01 |
| N0-vs-N1 |
2.828800E-01 |
|
|
